cerrar
Tagged with access,

Miha Kline – Country Manager, Eli Lilly Czech Republic…
Miha Kline has been with Eli Lilly for the past 15 years, becoming Country Manager Czech Republic and Slovakia four years ago. Kline shares his…

Mexico: Despite Hurdles, Pharma Market Remains Attractive
The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP…

Biocon’s New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an…

FDA Drugs Approved in 2019
In 2019, the US FDA's Center for Drug Evaluation and Research approved 42 novel drugs, down from 59 drugs approved in 2018. Novartis had four drugs…

UAE: A World Leader for Early Access to Innovation
The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates the process and eliminates long…

The Role of Cross-Sector Collaborations in Advancing Access to…
The IFPMA’s Greg Perry shares some of the key findings from a panel discussion on access to healthcare products at the 2019 World Health Summit in…

Michelle Werner – Country President Nordics and Baltics,…
Michelle Werner, country president for AstraZeneca’s Nordics and Baltics region, highlights the company’s strong connections with local…

Shuhei Sekiguchi – Managing Director, Janssen Taiwan
Shuhei Sekiguchi, recently-appointed managing director of Janssen Taiwan, discusses how his vast experience in marketing and sales will help him in…

Berkeley Vincent – Managing Director Nordics and Baltics,…
Berkeley Vincent, managing director of Janssen in the Nordics and Baltics, discusses the challenges of the digital future for the Swedish affiliate…

Pontus Billstam – Managing Director, Otsuka Pharma Nordics…
A relative newcomer to the Nordic countries, Otsuka has successfully built a strong foothold in the region. Pontus Billstam, managing director for the…

Proposed Solutions to the Access Challenges Facing Cancer…
Janssen's EMEA market access head Martin Price outlines the regulatory changes that need to be made for patients across Europe to better access…

Niels Abel Bonde – Managing Director, Novo Nordisk Sweden
Niels Abel Bonde, general manager of Novo Nordisk Sweden, explains the strategic significance of the Swedish market as an innovation-driven…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here